11 – 20 of 36
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Clinical protein science in translational medicine targeting malignant melanoma
(
- Contribution to journal › Article
-
Mark
Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma
(
- Contribution to journal › Article
-
Mark
Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics
(
- Contribution to journal › Article
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
(
- Contribution to journal › Article
- 2018
-
Mark
Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
(
- Contribution to journal › Article
- 2017
-
Mark
Cancer heterogeneity determined by functional proteomics
(
- Contribution to journal › Article
-
Mark
Limited tumor tissue drug penetration contributes to primary resistance against angiogenesis inhibitors
(
- Contribution to journal › Article
-
Mark
Merging clinical chemistry biomarker data with a COPD database - building a clinical infrastructure for proteomic studies
(
- Contribution to journal › Article
-
Mark
Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
(
- Contribution to journal › Article
- 2016
-
Mark
Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study.
(
- Contribution to journal › Article